The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Quantitative Analysis of HER2-mediated Effects on HER2 and Epidermal Growth Factor Receptor Endocytosis
Open accessAbstract
Endocytic trafficking plays an important role in the regulation of the epidermal growth factor receptor (EGFR) family. Many cell types express multiple EGFR family members (including EGFR, HER2, HER3, and/or HER4) that interact to form an array of homo- and heterodimers. Differential trafficking of these receptors should strongly affect signaling through this system by changing substrate access and heterodimerization efficiency. Because of the complexity of these dynamic processes, we used a quantitative and computational model to understand their integrated operation. Parameters characterizing EGFR and HER2 interactions were determined using experimental data obtained from mammary epithelial cells constructed to express different levels of HER2, enabling us to estimate receptor-specific internalization rate constants and dimer uncoupling rate constants. Significant novel results obtained from this work are as follows: first, that EGFR homodimerization and EGFR/HER2 heterodimerization occur with comparable affinities; second, that EGFR/HER2 heterodimers traffic as single entities. Furthermore, model predictions of the relationship of HER2 expression levels to consequent distribution of EGFR homodimers and EGFR/HER2 heterodimers suggest that the levels of HER2 found on normal cells are barely at the threshold necessary to drive efficient heterodimerization. Thus, altering HER2 concentrations, either overall or local, could provide an effective mechanism for regulating EGFR/HER2 heterodimerization and may explain why HER2 overexpression found in some cancers has such a profound effect on cell physiology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760
Untangling the ErbB signalling network
Yarden, Y., & Sliwkowski, M. X. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35052073 · Cited by 6,974
Research works printed but not linked: 49
- Alroy, 1997, FEBS Lett., 410, 83, 10.1016/S0014-5793(97)00412-2 · DOI · Paper page
- Tzahar, 1996, Mol. Cell. Biol., 16, 5276, 10.1128/MCB.16.10.5276 · DOI · Paper page
- Qian, 1994, Proc. Natl. Acad. Sci. U. S. A., 91, 1500, 10.1073/pnas.91.4.1500 · DOI
- Graus-Porta, 1997, EMBO J., 16, 1647, 10.1093/emboj/16.7.1647 · DOI · Paper page
- Riese, 1998, Bioessays, 20, 41, 10.1002/(SICI)1521-1878(199801)20:1<41::AID-BIES7>3.0.CO;2-V · DOI · Paper page
- DiFiore, 1987, Science, 237, 178, 10.1126/science.2885917 · DOI · Paper page
- Yu, 2000, Bioessays, 22, 673, 10.1002/1521-1878(200007)22:7<673::AID-BIES10>3.0.CO;2-A · DOI
- Spencer, 2000, J. Cell Biol., 148, 385, 10.1083/jcb.148.2.385 · DOI · Paper page
- Brandt, 1999, FASEB J., 13, 1939, 10.1096/fasebj.13.14.1939 · DOI
- French, 1994, J. Biol. Chem., 269, 15749, 10.1016/S0021-9258(17)40744-7 · DOI
- Wiley, 1988, J. Cell Biol., 107, 801, 10.1083/jcb.107.2.801 · DOI · Paper page
- Wells, 1990, Science, 247, 962, 10.1126/science.2305263 · DOI · Paper page
- Carpenter, 2000, Bioessays, 22, 697, 10.1002/1521-1878(200008)22:8<697::AID-BIES3>3.0.CO;2-1 · DOI · Paper page
- van der Geer, 1994, Annu. Rev. Cell Biol., 10, 251, 10.1146/annurev.cb.10.110194.001343 · DOI · Paper page
- Sorkin, 1993, Bioessays, 15, 375, 10.1002/bies.950150603 · DOI · Paper page
- Kurten, 1996, Science, 272, 1008, 10.1126/science.272.5264.1008 · DOI · Paper page
- Worthylake, 1999, J. Biol. Chem., 274, 8865, 10.1074/jbc.274.13.8865 · DOI · Paper page
- Sorkin, 1993, Oncogene, 8, 3021
- Baulida, 1996, J. Biol. Chem., 271, 5251, 10.1074/jbc.271.9.5251 · DOI · Paper page
- Muthuswamy, 1999, Mol. Cell. Biol., 19, 6845, 10.1128/MCB.19.10.6845 · DOI · Paper page
- Wang, 1999, Mol. Biol. Cell, 10, 1621, 10.1091/mbc.10.5.1621 · DOI · Paper page
- Hendriks, 2003, Cancer Res., 63, 1130
- Winkler, 1989, Biochemistry, 28, 6373, 10.1021/bi00441a033 · DOI
- Fendly, 1990, Cancer Res., 50, 1550
- Sliwkowski, 1994, J. Biol. Chem., 269, 14661, 10.1016/S0021-9258(17)36676-0 · DOI · Paper page
- D'Souza, 1993, Oncogene, 8, 1797
- Wiley, 1981, Cell, 25, 433, 10.1016/0092-8674(81)90061-1 · DOI · Paper page
- Lund, 1990, J. Biol. Chem., 265, 15713, 10.1016/S0021-9258(18)55456-9 · DOI · Paper page
- Wiley, 1982, J. Biol. Chem., 257, 4222, 10.1016/S0021-9258(18)34709-4 · DOI · Paper page
- Penuel, 2002, J. Biol. Chem., 277, 28468, 10.1074/jbc.M202510200 · DOI
- Mendrola, 2002, J. Biol. Chem., 277, 4704, 10.1074/jbc.M108681200 · DOI · Paper page
- Yu, 2002, Mol. Biol. Cell, 13, 2547, 10.1091/mbc.01-08-0411 · DOI · Paper page
- Burke, 1999, J. Cell. Physiol., 180, 448, 10.1002/(SICI)1097-4652(199909)180:3<448::AID-JCP16>3.0.CO;2-8 · doi:10.1002/(sici)1097-4652(199909)180:3<448::aid-jcp16>3.0.co;2-8
- Shea, 1997, Biophys. J., 73, 2949, 10.1016/S0006-3495(97)78323-1 · doi:10.1016/s0006-3495(97)78323-1
- Mahama, 1994, Biophys. J., 67, 1345, 10.1016/S0006-3495(94)80606-X · doi:10.1016/s0006-3495(94)80606-x
- Wiley, 1991, J. Biol. Chem., 266, 11083, 10.1016/S0021-9258(18)99131-3 · DOI · Paper page
- Kholodenko, 1999, J. Biol. Chem., 274, 30169, 10.1074/jbc.274.42.30169 · DOI · Paper page
- Schoeberl, 2002, Nat. Biotechnol., 20, 370, 10.1038/nbt0402-370 · DOI · Paper page
- Lotti, 1992, Exp. Cell Res., 202, 274, 10.1016/0014-4827(92)90075-J · doi:10.1016/0014-4827(92)90075-j
- Drebin, 1985, Cell, 41, 695, 10.1016/S0092-8674(85)80050-7 · DOI · Paper page
- Klapper, 1997, Oncogene, 14, 2099, 10.1038/sj.onc.1201029 · DOI · Paper page
- Worthylake, 1997, J. Biol. Chem., 272, 8594, 10.1074/jbc.272.13.8594 · DOI
- Blakely, 2000, Nat. Biotechnol., 18, 218, 10.1038/72686 · DOI
- Tanner, 1999, J. Biol. Chem., 274, 35985, 10.1074/jbc.274.50.35985 · DOI
- Ferguson, 2000, EMBO J., 19, 4632, 10.1093/emboj/19.17.4632 · DOI
- Meier, 1997, J. Neurosci., 17, 6534, 10.1523/JNEUROSCI.17-17-06534.1997 · DOI
- Ohno, 2002, Oncogene, 21, 7042, 10.1038/sj.onc.1205852 · DOI
- Lenferink, 1998, EMBO J., 17, 3385, 10.1093/emboj/17.12.3385 · DOI · Paper page
- Pinkas-Kramarski, 1998, Mol. Cell. Biol., 18, 6090, 10.1128/MCB.18.10.6090 · DOI
Cited by
Moasser, M. M. (2007) · Oncogene · doi:10.1038/sj.onc.1210477 · Cited by 1,219
Endocytosis and intracellular trafficking of ErbBs
Sorkin, A., & Goh, L. K. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.07.029 · Cited by 756
Antibody–drug conjugates: current status and future directions
Perez, H. L., Cardarelli, P. M., Deshpande, S., Gangwar, S., Schroeder, G. M., Vite, G. D., & Borzilleri, R. M. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2013.11.004 · Cited by 470
Chen, W. W., Schoeberl, B., Jasper, P. J., Niepel, M., Nielsen, U. B., Lauffenburger, D. A., & Sorger, P. K. (2009) · Molecular Systems Biology · doi:10.1038/msb.2008.74 · Cited by 391
Self-citationRudnick, S. I., Lou, J., Shaller, C. C., Tang, Y., Klein-Szanto, A. J. P., Weiner, L. M., Marks, J. D., & Adams, G. P. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2277 · Cited by 365
Computational modelling of the receptor-tyrosine-kinase-activated MAPK pathway
Orton, R. J., Sturm, O. E., Vyshemirsky, V., Calder, M., Gilbert, D. R., & Kolch, W. (2005) · Biochemical Journal · doi:10.1042/bj20050908 · Cited by 355
Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer
Meric-Bernstam, F., Johnson, A. M., Dumbrava, E. E. I., Raghav, K., Balaji, K., Bhatt, M., Murthy, R. K., Rodon, J., & Piha-Paul, S. A. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2275 · Cited by 349
The complexity of targeting EGFR signalling in cancer: From expression to turnover
Sebastian, S., Settleman, J., Reshkin, S. J., Azzariti, A., Bellizzi, A., & Paradiso, A. (2006) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.06.001 · Cited by 260
Affinity and Avidity in Antibody-Based Tumor Targeting
Rudnick, S. I., & Adams, G. P. (2009) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2009.0627 · Cited by 237
Bouhaddou, M., Barrette, A. M., Stern, A. D., Koch, R. J., DiStefano, M. S., Riesel, E. A., Santos, L. C., Tan, A. L., Mertz, A. E., & Birtwistle, M. R. (2018) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1005985 · Cited by 58
EHD1 and RUSC2 Control Basal Epidermal Growth Factor Receptor Cell Surface Expression and Recycling
Tom, E. C., Mushtaq, I., Mohapatra, B. C., Luan, H., Bhat, A. M., Zutshi, N., Chakraborty, S., Islam, N., Arya, P., Bielecki, T. A., et al. (2020) · Molecular and Cellular Biology · doi:10.1128/mcb.00434-19 · Cited by 13
Metadata
- Authors
- Hendriks, B. S., Opresko, L. K., Wiley, H. S., & Lauffenburger, D.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-06
- Volume
- 278
- Issue
- 26
- Pages
- 23343-23351
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2078112275
- Cited by
- 179
- References
- 2
- FWCI
- 4.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6340 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.